Numira

Salt Lake City, United States Founded: 2005 • Age: 21 yrs
Numira is a specialty preclinical CRO specializing in microCT imaging, image analysis, histology, and 3D cancer cell profiling.

About Numira

Numira was a Healthcare company based in Salt Lake City (United States) founded in 2005 by Michael Beeuwsaert and David Weinstein. Numira is a specialty preclinical CRO specializing in microCT imaging, image analysis, histology, and 3D cancer cell profiling. It operates on a B2B model. Numira has raised $5.78 million across 2 funding rounds from investors including Pasadena Angels, Tech Coast Angels and Signal Peak. The company is recorded as dissolved. Its focus areas include Healthcare and Biotechnology, Clinical Research, Preclinical Services and Imaging and Analysis. Its competitors include Asterand Bioscience, StageBio and Numira Biosciences; 2 of its 3 listed competitors have raised funding.

Company details

Numira numira is a specialty preclinical cro specializing in microct imaging, image analysis, histology, and 3d cancer cell profiling through healthcare and biotechnology, clinical research, preclinical services, and imaging and analysis. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

  • Headquarters Salt Lake City, United States
  • Founders Michael Beeuwsaert, David Weinstein
  • Sectors
    Healthcare
  • Website numira.com
  • Social X
Operational Areas
Key Metrics
  • Total Equity Funding
    $5.78M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.28M (USD), Series A

    May 2009

  • Investors

Funding Insights of Numira

Numira has successfully raised a total of $5.78M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.28 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.78M
  • Total Rounds 2
  • Last Round Series A β€” $3.28M
  • First Round $2.5M

    (Mar 2007)

  • Investors Count 3

All 2 funding rounds of Numira with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2009$3.28MSeries A––
–
Mar 2007$2.5MSeries A––
Valuation history

3 investors in total: 3 institutional.

Investors in Numira

Numira has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Pasadena Angels, Tech Coast Angels and Signal Peak.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investments are facilitated by Pasadena Angels in Southern California startups.
2000pasadenaangels.comAltadena, United States
Angel Network for companies based in Southern California
techcoastangels.comLos Angeles, United States
Early-stage investments in US tech and life sciences are targeted.
spv.comSalt Lake City, United States
Premium access

Investor details for Numira

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Numira

2 people are tracked at Numira (2 in leadership).

NameRoleGroup
Michael Beeuwsaert
Co-FounderLeadership
David Weinstein
Co-FounderLeadership
Premium access

Complete people profiles for Numira

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Numira

3 dated milestones of Numira across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Numira is founded.
  2. Funding First funding round of $2.5M.
  3. Funding Latest funding round, Series A, of $3.3M.

Competitors of Numira

Numira has 3 listed competitors in our database, 2 of them funded. They include Asterand Bioscience, StageBio and Numira Biosciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asterandbio.com2000Detroit, United States$7.11M
Human tissue solutions for drug discovery research are supplied globally.
stagebio.com2001Mount Jackson, United States
Preclinical pathology services are provided for research and development needs.
numirabio.com2005Salt Lake, United States$5.78M
Online platform for fast deposits and retail in electronics and fashion categories.
Premium access

Detailed competitors of Numira

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Imaging Diagnostics

3 companies that operate in the same segment as Numira (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Handheld ultrasound devices are developed for whole-body medical imaging.
2011Guilford, Connecticut, United StatesUSD 350 MUSD 97.61 M464
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Ultrasound images are analyzed via AI-based software provided by Exo.
2015Redwood City, California, United StatesUSD 463.39 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Numira

Numira was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Numira is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Numira is a funded company, having raised a total of $5.78M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Mar 2007.

Numira numira is a specialty preclinical cro specializing in microct imaging, image analysis, histology, and 3d cancer cell profiling through healthcare and biotechnology, clinical research, preclinical services, and imaging and analysis. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

Numira's top competitors include Asterand Bioscience, StageBio and Numira Biosciences.

Numira has 3 investors. Key investors include Pasadena Angels, Tech Coast Angels, and Signal Peak.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available